I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
RIPK1 inhibitor ameliorates colitis by directly maintaining..:
Lu, Huimin
;
Li, Heng
;
Fan, Chen
...
Biochemical Pharmacology. 172 (2020) - p. 113751 , 2020
Link:
https://doi.org/10.1016/j.bcp.2019.113751
RT Journal T1
RIPK1 inhibitor ameliorates colitis by directly maintaining intestinal barrier homeostasis and regulating following IECs-immuno crosstalk
UL https://suche.suub.uni-bremen.de/peid=cr-10.1016_j.bcp.2019.113751&Exemplar=1&LAN=DE A1 Lu, Huimin A1 Li, Heng A1 Fan, Chen A1 Qi, Qing A1 Yan, Yuxi A1 Wu, Yanwei A1 Feng, Chunlan A1 Wu, Bing A1 Gao, Yuanzhuo A1 Zuo, Jianping A1 Tang, Wei PB Elsevier BV YR 2020 SN 0006-2952 JF Biochemical Pharmacology VO 172 SP 113751 LK http://dx.doi.org/https://doi.org/10.1016/j.bcp.2019.113751 DO https://doi.org/10.1016/j.bcp.2019.113751 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)